InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Poly(I:C) HMW | Human in vitro modeling identifies adjuvant combinations that unlock antigen ... | 2024 | J Mol Biol. | Thomas S. et al. | DOI: 10.1016/j.jmb.2024.168446 |
3p-hpRNA - RIG-I agonist | Human in vitro modeling identifies adjuvant combinations that unlock antigen ... | 2024 | J Mol Biol. | Thomas S. et al. | DOI: 10.1016/j.jmb.2024.168446 |
R848 (Resiquimod) | Human in vitro modeling identifies adjuvant combinations that unlock antigen ... | 2024 | J Mol Biol. | Thomas S. et al. | DOI: 10.1016/j.jmb.2024.168446 |
TDB | Human in vitro modeling identifies adjuvant combinations that unlock antigen ... | 2024 | J Mol Biol. | Thomas S. et al. | DOI: 10.1016/j.jmb.2024.168446 |
MDP | Human in vitro modeling identifies adjuvant combinations that unlock antigen ... | 2024 | J Mol Biol. | Thomas S. et al. | DOI: 10.1016/j.jmb.2024.168446 |
Puromycin | Oral cancer cell to endothelial cell communication via exosomal miR-21/RMND5A... | 2024 | BMC Oral Health | Sun Y.Q. et al. | DOI: 10.1186/s12903-024-03852-3 |
RAW-Blue™ Cells | Uptake of Cyclodextrin Nanoparticles by Macrophages is Dependent on Particle ... | 2024 | ACS Appl Bio Mater. | Soni S.S. et al. | DOI: 10.1021/acsabm.3c00985 |
QUANTI-Blue™ | Uptake of Cyclodextrin Nanoparticles by Macrophages is Dependent on Particle ... | 2024 | ACS Appl Bio Mater. | Soni S.S. et al. | DOI: 10.1021/acsabm.3c00985 |
ODN 1826 VacciGrade™ | Vaccine design via antigen reorientation. | 2024 | Nat Chem Biol. | Xu D. et al. | DOI: 10.1038/s41589-023-01529-6 |
Alhydrogel® adjuvant 2% | Vaccine design via antigen reorientation. | 2024 | Nat Chem Biol. | Xu D. et al. | DOI: 10.1038/s41589-023-01529-6 |
G418 (Geneticin) | Lymphocyte-Specific Protein 1 Regulates Expression and Stability of Endotheli... | 2024 | Biomolecules | Smeir M. et al. | DOI: 10.3390/biom14010111 |
RAW-Blue™ Cells | Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Du... | 2024 | ACS Nano | Ou B.S. et al. | DOI: 10.1021/acsnano.3c09700 |
Human TLR9 Reporter THP-1 Cells | Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Du... | 2024 | ACS Nano | Ou B.S. et al. | DOI: 10.1021/acsnano.3c09700 |
QUANTI-Blue™ | Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Du... | 2024 | ACS Nano | Ou B.S. et al. | DOI: 10.1021/acsnano.3c09700 |
QUANTI-Luc™: Luciferase Detection Reagent | Gel-mediated recruitment of conventional type 1 dendritic cells potentiates t... | 2024 | Biomaterials | Wu Y. et al. | DOI: 10.1016/j.biomaterials.2024.122470 |
293-Dual™ mSTING Cells | Gel-mediated recruitment of conventional type 1 dendritic cells potentiates t... | 2024 | Biomaterials | Wu Y. et al. | DOI: 10.1016/j.biomaterials.2024.122470 |
Zeocin® | A novel, robust peptidyl-lys metalloendopeptidase from Trametes coccinea reco... | 2024 | Appl Microbiol Biotechnol. | Ahmed U. et al. | DOI: 10.1007/s00253-023-12986-3 |
Poly(I:C) HMW | UNC93B1 variants underlie TLR7-dependent autoimmunity. | 2024 | Sci Immunol. | Wolf C. et al. | DOI: 10.1126/sciimmunol.adi9769 |
Puromycin | Comparison of antibody-based immunotherapeutics for malignant hematological d... | 2024 | Blood Adv. | Albring J.C. et al. | DOI: 10.1182/bloodadvances.2023011647 |
Primocin® | Organoids derived from patients provide a new opportunity for research and in... | 2024 | Mol Cancer | Fang X. et al. | DOI: 10.1186/s12943-023-01901-z |